These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8458025)

  • 1. Oxygen free radicals, reperfusion injury, endothelial cells, and von Willebrand factor.
    Blann AD; Midgley HS; Burrows G; Maxwell S; Utting S; Waite MA
    Cardiovasc Res; 1993 Jan; 27(1):141-2. PubMed ID: 8458025
    [No Abstract]   [Full Text] [Related]  

  • 2. Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplasty.
    Blann A; Midgley H; Burrows G; Maxwell S; Utting S; Davies M; Waite M; McCollum C
    Coron Artery Dis; 1993 Oct; 4(10):905-10. PubMed ID: 8269197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of neutrophils in ischemic and reperfusion myocardial injury].
    Maianskiĭ DN; Maianskaia SD
    Ter Arkh; 2001; 73(12):84-8. PubMed ID: 11858120
    [No Abstract]   [Full Text] [Related]  

  • 4. Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion.
    Stangl V; Baumann G; Stangl K; Felix SB
    Cardiovasc Res; 2002 Jan; 53(1):12-30. PubMed ID: 11744010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation, neutrophils, and oxygen radicals in reperfusion injury.
    Lucchesi BR
    Stroke; 1993 Dec; 24(12 Suppl):I41-7; discussion I38-40. PubMed ID: 8249019
    [No Abstract]   [Full Text] [Related]  

  • 6. The double-edge sword of TNF-alpha in ischemia-reperfusion injury.
    Durán WN
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2221-2. PubMed ID: 18849327
    [No Abstract]   [Full Text] [Related]  

  • 7. Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis.
    Farrell AJ; Williams RB; Stevens CR; Lawrie AS; Cox NL; Blake DR
    Ann Rheum Dis; 1992 Oct; 51(10):1117-22. PubMed ID: 1444624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypoxia impairs endothelial antithrombotic properties through increased von Willebrand factor release and decreased NO production].
    Hattori R; Uchizumi H; Yui Y; Sasayama S
    Jpn Circ J; 1993; 57 Suppl 4():1184-5. PubMed ID: 7966942
    [No Abstract]   [Full Text] [Related]  

  • 9. New insights into the non-hemostatic role of von Willebrand factor in endothelial protection.
    Agostini S; Lionetti V
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1183-1189. PubMed ID: 28715643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balance of nitric oxide and reactive oxygen species in myocardial reperfusion injury and protection.
    Folino A; Losano G; Rastaldo R
    J Cardiovasc Pharmacol; 2013 Dec; 62(6):567-75. PubMed ID: 23921313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals.
    Sellke FW; Shafique T; Ely DL; Weintraub RM
    Circulation; 1993 Nov; 88(5 Pt 2):II395-400. PubMed ID: 8222185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease.
    Blann AD
    J Rheumatol; 1993 Sep; 20(9):1469-71. PubMed ID: 8164200
    [No Abstract]   [Full Text] [Related]  

  • 13. Preeclampsia, von Willebrand factor antigen, and endothelial cells.
    Blann AD
    Am J Obstet Gynecol; 1992 Feb; 166(2):769-70. PubMed ID: 1536264
    [No Abstract]   [Full Text] [Related]  

  • 14. Markers and Biomarkers of Endothelium: When Something Is Rotten in the State.
    Goncharov NV; Nadeev AD; Jenkins RO; Avdonin PV
    Oxid Med Cell Longev; 2017; 2017():9759735. PubMed ID: 29333215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia.
    Mehlhorn U; Krahwinkel A; Geissler HJ; LaRosee K; Fischer UM; Klass O; Suedkamp M; Hekmat K; Tossios P; Bloch W
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):178-83. PubMed ID: 12539002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].
    Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G
    Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of factor VIII von Willebrand factor in endothelial cells in first-trimester fetuses.
    Travis PA; Bovill EG; Hamill B; Tindle BH
    Arch Pathol Lab Med; 1988 Jan; 112(1):40-2. PubMed ID: 2447849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perturbation of cultured human vascular endothelial cells by phorbol ester or thrombin alters the cellular von Willebrand factor distribution.
    Reinders JH; Vervoorn RC; Verweij CL; van Mourik JA; de Groot PG
    J Cell Physiol; 1987 Oct; 133(1):79-87. PubMed ID: 3499441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase inhibition prevents reactive oxygen species induced inhibition of aldehyde dehydrogenase2 activity.
    Wei SJ; Xing JH; Wang BL; Xue L; Wang JL; Li R; Qin WD; Wang J; Wang XP; Zhang MX; Chen YG
    Biochim Biophys Acta; 2013 Mar; 1833(3):479-86. PubMed ID: 23159776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor: a marker of endothelial damage?
    Mannucci PM
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1359-62. PubMed ID: 9743222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.